https://www.selleckchem.com/pr....oducts/bezafibrate.h
Antipsychotics are the main line of treatment for schizophrenia. Even though there are significant rates of medication drop out due to side effects and limited response of approximately 50% of patients. This is likely due to incomplete knowledge in how these drugs act at the molecular level. To improve treatment efficacy during the critical early stages of schizophrenia, we aimed to identify molecular signatures at baseline (T for prediction of a positive response to the atypical antipsychotics olanzapine and risperidone after 6 w
Like
Comment
Share
